Germany to consider OTC switch for adapalene

4 December 2015 - Deborah Wilkes

Archived

Germany is set to consider an application to switch medicines containing the topical retinoid adapalene from prescription to non-prescription status for treating acne.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: